Mark Sabat
20Patents
3h-index
54Co-inventors
62Inventor score
Filing activity: Mar 17, 2003 → Jan 27, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7256196B1 | Purine cytokine inhibitors | Chemistry; Metallurgy | 16 | Expired |
| US10543212B2 | Substituted amines for treating cardiac diseases | Human Necessities | 7 | Active |
| US7319102B1 | Pyrrolo[2,3-d]pyrimidine cytokine inhibitors | Human Necessities | 5 | Expired |
| US9073918B2 | Pyrazolo[4,3-b]pyridine-7-amine inhibitors of ALK5 | Human Necessities | 2 | Active |
| US8530499B2 | Glucokinase activators | Chemistry; Metallurgy | 2 | Active |
| US9402841B2 | Pyridinyl and fused pyridinyl triazolone derivatives | Chemistry; Metallurgy | 1 | Active |
| US6849627B2 | 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines | Chemistry; Metallurgy | 1 | Expired |
| US8163779B2 | Glucokinase activators | Chemistry; Metallurgy | 1 | Active |
| US9801872B2 | Pyridinyl and fused pyridinyl triazolone derivatives | Chemistry; Metallurgy | 1 | Active |
| US8563730B2 | Pyrazole and fused pyrazole glucokinase activators | Emerging Cross-Sectional Technologies | 1 | Active |
| US9598424B2 | Heteroarylamide inhibitors of TBK1 | Chemistry; Metallurgy | 0 | Active |
| US11197858B2 | Substituted amines for treating cardiac diseases | Human Necessities | 0 | Active |
| US7402589B2 | Tri-substituted ureas as cytokine inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9365566B2 | Cinnoline derivatives | Chemistry; Metallurgy | 0 | Active |
| US9139598B2 | Glucokinase activators | Emerging Cross-Sectional Technologies | 0 | Active |
| US8173645B2 | Glucokinase activators | Chemistry; Metallurgy | 0 | Active |
| US8034822B2 | Glucokinase activators | Chemistry; Metallurgy | 0 | Active |
| US10307414B2 | Pyridinyl and fused pyridinyl triazolone derivatives | Chemistry; Metallurgy | 0 | Active |
| US7482356B2 | Bicyclic pyrazolone cytokine inhibitors | Human Necessities | 0 | Expired |
| US7449474B2 | Tri-substituted ureas as cytokine inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.